Market map · Europe

Rare disease market map: Europe

19 rare disease startups based in Europe that have raised money in rounds we track, placed in 3 segments by what each says it does. Together they have raised $695M; the biggest segment is other rare disease therapies.

19startups on the map
3segments
$695Mraised between them
Other rare disease therapiesmost funded segment

Other rare disease therapies

10

Diagnosis and genomics

5

Gene therapies

4

Segment by segment

Other rare disease therapies

10 startups · $565M raised

  1. Quercis PharmaQuercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.Switzerland$150M
  2. VectivBioVectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.Switzerland$125M
  3. Amryt PharmaAmryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.Ireland$125M
  4. DynacureDynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.France$109M
  5. Scenic BiotechScenic Biotech is a biopharmaceutical company based in Amsterdam, Netherlands, founded in 2017.Netherlands$31M
  6. SOM BiotechSOM Biotech is a privately held biopharmaceutical company based in Barcelona, Spain, founded in December 2009.Spain$7.9M
  7. MindMaze formerly Relief TherapeuticsMindMaze formerly Relief Therapeutics develops biopharmaceutical and neurotechnology solutions for neurological and rare diseases.Switzerland$5.8M
  8. LudocareLudocare is a French startup founded in 2017 and based in Lyon, specializing in digital therapeutics for pediatric patients.France$4.4M

Diagnosis and genomics

5 startups · $14M raised

  1. GenomeUpDigital biotech startup offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for rare diItaly$4.9M
  2. SeqOneSeqOne is a biotechnology company based in Montpellier, France, founded in 2017.France$3.4M
  3. Saventic HealthSaventic Health is a med-tech company based in Toruń, Poland, founded in 2019 by Szymon Piątkowski and Professor Grzegorz Basak.Poland$2.1M
  4. MendelianMendelian is helping doctors diagnose rare genetic diseases faster.United Kingdom$1.7M
  5. gMendelgMendel is a medical technology company based in Denmark, founded in 2020.Denmark$1.4M

Gene therapies

4 startups · $116M raised

  1. Vivet TherapeuticsVivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.France$96M
  2. AAAVLifeWildlife engages in developing gene therapy for the treatment of rare diseases.France$12M
  3. Alia TherapeuticsAlia Therapeutics is an innovative biotechnology company based in Trento, Italy, founded in October 2018.Italy$4.8M
  4. BlackfinBioBlackfinBio is a biotechnology company based in the UK and a spinout from the University of Sheffield.United Kingdom$3.5M

How this map is made. Every startup here has raised money in rounds we track, and is based in Europe. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in rare disease, and goes to the first segment whose words it carries. Each segment shows its best-funded first. Rebuilt nightly; updated 15 November 2026.

More market maps

All maps
Market mapRare disease market map70 startups · 5 segments · $5.0BInvestors mapWho invests in rare disease37 investors · 3 segmentsMarket map · United StatesRare disease market map: United States36 startups · 3 segments · $3.8BMarket map · EuropeFintech market map: Europe409 startups · 8 segments · $35BMarket map · EuropeEdtech market map: Europe247 startups · 7 segments · $1.7BMarket map · EuropeRobotics market map: Europe76 startups · 6 segments · $3.3B

Who backs rare disease?

Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.

Find their investorsTop lists